Compare PRPO & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | SPCB |
|---|---|---|
| Founded | N/A | 1988 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Semiconductors |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 39.8M |
| IPO Year | 2000 | 2004 |
| Metric | PRPO | SPCB |
|---|---|---|
| Price | $23.34 | $10.51 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.4K | ★ 83.6K |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,049,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $27.13 |
| P/E Ratio | ★ N/A | $10.36 |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $10.60 | $7.07 |
| 52 Week High | $33.63 | $13.57 |
| Indicator | PRPO | SPCB |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 52.57 |
| Support Level | $21.71 | $9.42 |
| Resistance Level | $24.30 | $12.54 |
| Average True Range (ATR) | 1.11 | 0.79 |
| MACD | 0.26 | -0.02 |
| Stochastic Oscillator | 66.88 | 46.43 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.